AlphAIalphai — Financial news for AI agents
tradingview.comAUG 211 min read

Latham Group Secures $375 Million Credit Facilities Led by Jefferies Finance; Replaces 2022 Loan

Latham Group (SWIM) secured $375 million in new credit facilities, including a $75 million revolving credit line and a $300 million term loan, led by Jefferies Finance. The facilities will refinance and extend the company's maturities, replacing a 2022 Barclays-led agreement. The revolver matures in 2031, and the term loan in 2033.

Original reporting
tradingview.com
Published Aug 21, 2026, 12:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Latham Group Secures $375 Million Credit Facilities Led by Jefferies Finance; Replaces 2022 Loan — source image
Source · tradingview.com
Decision brief

The 30-second read

Med
01

Why it matters

The $375 M credit package strengthens liquidity and extends debt maturities, likely viewed positively by investors.

02

Market read

Primary corporate financing news with material dollar amount; relevant for debt‑focused traders.

03

What to watch

Potential covenants and mandatory prepayment terms could constrain future cash flow.

Relevance 7/10Novelty 8/10Timing: effective Aug 20 2026

Background

Latham Group is refinancing its 2022 Barclays‑led credit facility.

Market effects

Sector

May signal increased credit availability for mid‑cap industrial firms.

Regional

Limited to U.S. markets where Latham Group trades.

Global

Low

Counterpoint

What could challenge this read

If the facility terms are tighter than expected, the stock could face pressure.

Key entities

  • Lender
    Jefferies Finance

    Administrative agent for the new credit facility.

  • Former Lender
    Barclays Bank

    Provider of the terminated 2022 credit agreement.

Read at source← All news

Related articles

AUG 22
Med

Latham Group Refinances Capital Structure with New Credit Facilities

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

theglobeandmail.com1 min
AUG 21
$HOWLHighAI 8/10

Latham & Watkins Advises on Oversubscribed US$150 Million Private Placement in Connection With Werewolf Therapeutics and Ambros Therapeutics’ Reverse Merger Transaction

Werewolf Therapeutics (HOWL) and Ambros Therapeutics agreed to merge in an all-stock deal. The combined company will focus on Ambros' neridronate program for CRPS-1 and trade as AMBX. They secured $150M in private placement from healthcare investors. Latham & Watkins advised on the transaction.

lw.com2 min
AUG 21
$GOSSHighAI 9/10

Latham Advises Gossamer Bio on Up to US$250 Million Structured Private Placement, Including US$150 Million of Committed Capital

Gossamer Bio (GOSS) plans a private placement of up to $250M, including $150M committed capital. The deal involves new and existing investors and is contingent on FDA actions for seralutinib. Latham & Watkins advised the company. The financing follows Gossamer's reacquisition of seralutinib rights and precedes its planned NDA submission in September 2026.

legaldesire.com2 min
AUG 21
MedAI 8/10

Latham & Watkins Advises on Andersen Group’s US$188.5 Million Secondary Offering

Andersen Group Inc. announced a secondary offering of 4.28 million shares of Class A common stock at $44 per share, with gross proceeds of $188.5 million for selling stockholders. The offering is expected to close on August 21, 2026, with underwriters having a 30-day option to purchase additional shares. Andersen is not selling shares and will not receive proceeds. Latham & Watkins LLP represents the underwriters.

legaldesire.com2 min
AUG 18
$FULCMedAI 8/10

Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger

Fulcrum Therapeutics (Nasdaq: FULC) and Slate Medicines announced a definitive all-stock merger. The combined company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq as SLTE. Slate secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with other healthcare investors participating.

lw.com2 min